APO Research
Talk to an analyst

APO RESEARCH · REPORT

Veterinary Lyme Disease Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Veterinary Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026

27 December 2025195 pages

Choose your research edition.

Industry ResearchVeterinary Lyme Disease Vaccine Industry Research Report 2026116 pages · $2,950 USDIndustry Growth & TrendsGlobal Veterinary Lyme Disease Vaccine Industry Growth and Trends Forecast to 203291 pages · $3,450 USDMarket StructureGlobal Veterinary Lyme Disease Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032184 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Veterinary Lyme Disease Vaccine Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal Veterinary Lyme Disease Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Veterinary Lyme Disease Vaccine market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Veterinary Lyme Disease Vaccine is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Veterinary Lyme Disease Vaccine market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Veterinary Lyme Disease Vaccine market include Bioveta, Zoetis, Boehringer Ingelheim, Elanco and Merck, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Veterinary Lyme Disease Vaccine market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Veterinary Lyme Disease Vaccine and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Veterinary Lyme Disease Vaccine sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Veterinary Lyme Disease Vaccine market size, projected growth trends, production technologies, key applications, and end-use industries.

Veterinary Lyme Disease Vaccine Segment by Company

Bioveta

Zoetis

Boehringer Ingelheim

Elanco

Merck

Veterinary Lyme Disease Vaccine Segment by Type

Monovalent Vaccines

Combination Vaccines

Veterinary Lyme Disease Vaccine Segment by Application

Canine

Feline

Others

Veterinary Lyme Disease Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Veterinary Lyme Disease Vaccine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Veterinary Lyme Disease Vaccine market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Veterinary Lyme Disease Vaccine significant trends, drivers, influence factors in global and regions.

6. To analyze Veterinary Lyme Disease Vaccine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Veterinary Lyme Disease Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Veterinary Lyme Disease Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Veterinary Lyme Disease Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Veterinary Lyme Disease Vaccine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Veterinary Lyme Disease Vaccine industry.

Chapter 3: Detailed analysis of Veterinary Lyme Disease Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Veterinary Lyme Disease Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Veterinary Lyme Disease Vaccine in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Veterinary Lyme Disease Vaccine Industry Trends Table 2. Veterinary Lyme Disease Vaccine Industry Drivers Table 3. Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges Table 4. Veterinary Lyme Disease Vaccine Industry Restraints Table 5. Global Veterinary Lyme Disease Vaccine Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Veterinary Lyme Disease Vaccine Revenue Share by Company (2021-2026) Table 7. Global Veterinary Lyme Disease Vaccine Sales Volume by Company (K Units) & (2021-2026) Table 8. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Company (2021-2026) Table 9. Global Veterinary Lyme Disease Vaccine Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Veterinary Lyme Disease Vaccine Company Ranking, (2024-2026) & (USD Million) Table 11. Global Veterinary Lyme Disease Vaccine Key Company Manufacturing Base & Headquarters Table 12. Global Veterinary Lyme Disease Vaccine Company, Product Type & Application Table 13. Global Veterinary Lyme Disease Vaccine Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Veterinary Lyme Disease Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Monovalent Vaccines Table 18. Significant Companies of Combination Vaccines Table 19. Global Veterinary Lyme Disease Vaccine Sales Volume by Type 2021 VS 2025 VS 2032 (K Units) Table 20. Global Veterinary Lyme Disease Vaccine Sales Volume by Type (2021-2026) & (K Units) Table 21. Global Veterinary Lyme Disease Vaccine Sales Volume by Type (2027-2032) & (K Units) Table 22. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Type (2021-2026) Table 23. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Type (2027-2032) Table 24. Global Veterinary Lyme Disease Vaccine Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Veterinary Lyme Disease Vaccine Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Veterinary Lyme Disease Vaccine Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Veterinary Lyme Disease Vaccine Sales Value Share by Type (2021-2026) Table 28. Global Veterinary Lyme Disease Vaccine Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Canine Table 30. Significant Companies of Feline Table 31. Significant Companies of Others Table 32. Global Veterinary Lyme Disease Vaccine Sales Volume by Application 2021 VS 2025 VS 2032 (K Units) Table 33. Global Veterinary Lyme Disease Vaccine Sales Volume by Application (2021-2026) & (K Units) Table 34. Global Veterinary Lyme Disease Vaccine Sales Volume by Application (2027-2032) & (K Units) Table 35. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Application (2021-2026) Table 36. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Application (2027-2032) Table 37. Global Veterinary Lyme Disease Vaccine Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Veterinary Lyme Disease Vaccine Sales Value by Application (2021-2026) & (US$ Million) Table 39. Global Veterinary Lyme Disease Vaccine Sales Value by Application (2027-2032) & (US$ Million) Table 40. Global Veterinary Lyme Disease Vaccine Sales Value Share by Application (2021-2026) Table 41. Global Veterinary Lyme Disease Vaccine Sales Value Share by Application (2027-2032) Table 42. Global Veterinary Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Table 43. Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2026) & (K Units) Table 44. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2021-2026) Table 45. Global Veterinary Lyme Disease Vaccine Sales by Region (2027-2032) & (K Units) Table 46. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region (2027-2032) Table 47. Global Veterinary Lyme Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Veterinary Lyme Disease Vaccine Sales Value by Region (2021-2026) & (US$ Million) Table 49. Global Veterinary Lyme Disease Vaccine Sales Value Share by Region (2021-2026) Table 50. Global Veterinary Lyme Disease Vaccine Sales Value by Region (2027-2032) & (US$ Million) Table 51. Global Veterinary Lyme Disease Vaccine Sales Value Share by Region (2027-2032) Table 52. Global Veterinary Lyme Disease Vaccine Market Average Price (US$/Unit) by Region (2021-2026) Table 53. Global Veterinary Lyme Disease Vaccine Market Average Price (US$/Unit) by Region (2027-2032) Table 54. Global Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032 (K Units) Table 55. Global Veterinary Lyme Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 56. Global Veterinary Lyme Disease Vaccine Sales by Country (2021-2026) & (K Units) Table 57. Global Veterinary Lyme Disease Vaccine Sales Market Share by Country (2021-2026) Table 58. Global Veterinary Lyme Disease Vaccine Sales by Country (2027-2032) & (K Units) Table 59. Global Veterinary Lyme Disease Vaccine Sales Market Share by Country (2027-2032) Table 60. Global Veterinary Lyme Disease Vaccine Sales Value by Country (2021-2026) & (US$ Million) Table 61. Global Veterinary Lyme Disease Vaccine Sales Value Market Share by Country (2021-2026) Table 62. Global Veterinary Lyme Disease Vaccine Sales Value by Country (2027-2032) & (US$ Million) Table 63. Global Veterinary Lyme Disease Vaccine Sales Value Market Share by Country (2027-2032) Table 64. Bioveta Company Information Table 65. Bioveta Business Overview Table 66. Bioveta Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 67. Bioveta Veterinary Lyme Disease Vaccine Product Portfolio Table 68. Bioveta Recent Development Table 69. Zoetis Company Information Table 70. Zoetis Business Overview Table 71. Zoetis Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 72. Zoetis Veterinary Lyme Disease Vaccine Product Portfolio Table 73. Zoetis Recent Development Table 74. Boehringer Ingelheim Company Information Table 75. Boehringer Ingelheim Business Overview Table 76. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 77. Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio Table 78. Boehringer Ingelheim Recent Development Table 79. Elanco Company Information Table 80. Elanco Business Overview Table 81. Elanco Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 82. Elanco Veterinary Lyme Disease Vaccine Product Portfolio Table 83. Elanco Recent Development Table 84. Merck Company Information Table 85. Merck Business Overview Table 86. Merck Veterinary Lyme Disease Vaccine Sales (K Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 87. Merck Veterinary Lyme Disease Vaccine Product Portfolio Table 88. Merck Recent Development Table 89. Key Raw Materials Table 90. Raw Materials Key Suppliers Table 91. Veterinary Lyme Disease Vaccine Distributors List Table 92. Veterinary Lyme Disease Vaccine Customers List Table 93. Research Programs/Design for This Report Table 94. Authors List of This Report Table 95. Secondary Sources Table 96. Primary Sources List of Figures Figure 1. Veterinary Lyme Disease Vaccine Product Image Figure 2. Global Veterinary Lyme Disease Vaccine Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 4. Global Veterinary Lyme Disease Vaccine Sales (2021-2032) & (K Units) Figure 5. Global Veterinary Lyme Disease Vaccine Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Veterinary Lyme Disease Vaccine Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Monovalent Vaccines Image Figure 10. Combination Vaccines Image Figure 11. Global Veterinary Lyme Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032) & (K Units) Figure 12. Global Veterinary Lyme Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Type (2021-2032) Figure 14. Global Veterinary Lyme Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Veterinary Lyme Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Veterinary Lyme Disease Vaccine Sales Value Share by Type (2021-2032) Figure 17. Canine Image Figure 18. Feline Image Figure 19. Others Image Figure 20. Global Veterinary Lyme Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032) & (K Units) Figure 21. Global Veterinary Lyme Disease Vaccine Sales Volume Share 2021 VS 2025 VS 2032 Figure 22. Global Veterinary Lyme Disease Vaccine Sales Volume Share by Application (2021-2032) Figure 23. Global Veterinary Lyme Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 24. Global Veterinary Lyme Disease Vaccine Sales Value Share 2021 VS 2025 VS 2032 Figure 25. Global Veterinary Lyme Disease Vaccine Sales Value Share by Application (2021-2032) Figure 26. Global Veterinary Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 27. Global Veterinary Lyme Disease Vaccine Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 28. Global Veterinary Lyme Disease Vaccine Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 29. Global Veterinary Lyme Disease Vaccine Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 30. North America Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 31. North America Veterinary Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 32. Europe Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 33. Europe Veterinary Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 34. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 35. Asia-Pacific Veterinary Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 36. South America Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 37. South America Veterinary Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 38. Middle East & Africa Veterinary Lyme Disease Vaccine Sales Value (2021-2032) & (US$ Million) Figure 39. Middle East & Africa Veterinary Lyme Disease Vaccine Sales Value Share by Country (%), 2025 VS 2032 Figure 40. USA Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 41. USA Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 42. USA Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 43. Canada Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 44. Canada Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 45. Canada Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 46. Mexico Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 47. Mexico Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 48. Mexico Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 49. Germany Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 50. Germany Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 51. Germany Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 52. France Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 53. France Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 54. France Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 55. U.K. Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 56. U.K. Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 57. U.K. Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 58. Italy Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 59. Italy Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 60. Italy Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 61. Spain Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 62. Spain Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 63. Spain Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 64. Russia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 65. Russia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 66. Russia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 67. Netherlands Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 68. Netherlands Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 69. Netherlands Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 70. Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 71. Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 72. Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 73. China Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 74. China Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 75. China Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 76. Japan Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 77. Japan Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 78. Japan Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 79. South Korea Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 80. South Korea Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 81. South Korea Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 82. India Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 83. India Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 84. India Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 85. Australia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 86. Australia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 87. Australia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 88. Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 89. Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 90. Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 91. Brazil Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 92. Brazil Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 93. Brazil Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 94. Argentina Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 95. Argentina Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 96. Argentina Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 97. Chile Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 98. Chile Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 99. Chile Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 100. Colombia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 101. Colombia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 102. Colombia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 103. Peru Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 104. Peru Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 105. Peru Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 106. Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 107. Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 108. Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 109. Israel Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 110. Israel Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 111. Israel Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 112. UAE Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 113. UAE Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 114. UAE Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 115. Turkey Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 116. Turkey Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 117. Turkey Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 118. Iran Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 119. Iran Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 120. Iran Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 121. Egypt Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 122. Egypt Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032 & (%) Figure 123. Egypt Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032 & (%) Figure 124. Veterinary Lyme Disease Vaccine Value Chain Figure 125. Manufacturing Cost Structure Figure 126. Veterinary Lyme Disease Vaccine Sales Mode & Process Figure 127. Direct Comparison with Distribution Share Figure 128. Distributors Profiles Figure 129. Years Considered Figure 130. Research Process Figure 131. Key Executives Interviewed

Scope & coverage.

Types
  • Monovalent Vaccines
  • Combination Vaccines
Applications
  • Canine
  • Feline
  • Others
Companies covered
  • Bioveta
  • Zoetis
  • Boehringer Ingelheim
  • Elanco
  • Merck

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  4. 1.2.2 Global Veterinary Lyme Disease Vaccine Sales Volume (2021-2032)
  5. 1.2.3 Global Veterinary Lyme Disease Vaccine Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Veterinary Lyme Disease Vaccine Market Dynamics
  1. 2.1 Veterinary Lyme Disease Vaccine Industry Trends
  2. 2.2 Veterinary Lyme Disease Vaccine Industry Drivers
  3. 2.3 Veterinary Lyme Disease Vaccine Industry Opportunities and Challenges
  4. 2.4 Veterinary Lyme Disease Vaccine Industry Restraints
3 Veterinary Lyme Disease Vaccine Market by Company
  1. 3.1 Global Veterinary Lyme Disease Vaccine Company Revenue Ranking in 2025
  2. 3.2 Global Veterinary Lyme Disease Vaccine Revenue by Company (2021-2026)
  3. 3.3 Global Veterinary Lyme Disease Vaccine Sales Volume by Company (2021-2026)
  4. 3.4 Global Veterinary Lyme Disease Vaccine Average Price by Company (2021-2026)
  5. 3.5 Global Veterinary Lyme Disease Vaccine Company Ranking (2024-2026)
  6. 3.6 Global Veterinary Lyme Disease Vaccine Company Manufacturing Base and Headquarters
  7. 3.7 Global Veterinary Lyme Disease Vaccine Company Product Type and Application
  8. 3.8 Global Veterinary Lyme Disease Vaccine Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Veterinary Lyme Disease Vaccine Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Veterinary Lyme Disease Vaccine Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Veterinary Lyme Disease Vaccine Market by Type
  1. 4.1 Veterinary Lyme Disease Vaccine Type Introduction
  2. 4.1.1 Monovalent Vaccines
  3. 4.1.2 Combination Vaccines
  4. 4.2 Global Veterinary Lyme Disease Vaccine Sales Volume by Type
  5. 4.2.1 Global Veterinary Lyme Disease Vaccine Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Veterinary Lyme Disease Vaccine Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Veterinary Lyme Disease Vaccine Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Veterinary Lyme Disease Vaccine Sales Value by Type
  9. 4.3.1 Global Veterinary Lyme Disease Vaccine Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Veterinary Lyme Disease Vaccine Sales Value by Type (2021-2032)
  11. 4.3.3 Global Veterinary Lyme Disease Vaccine Sales Value Share by Type (2021-2032)
5 Veterinary Lyme Disease Vaccine Market by Application
  1. 5.1 Veterinary Lyme Disease Vaccine Application Introduction
  2. 5.1.1 Canine
  3. 5.1.2 Feline
  4. 5.1.3 Others
  5. 5.2 Global Veterinary Lyme Disease Vaccine Sales Volume by Application
  6. 5.2.1 Global Veterinary Lyme Disease Vaccine Sales Volume by Application (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Veterinary Lyme Disease Vaccine Sales Volume by Application (2021-2032)
  8. 5.2.3 Global Veterinary Lyme Disease Vaccine Sales Volume Share by Application (2021-2032)
  9. 5.3 Global Veterinary Lyme Disease Vaccine Sales Value by Application
  10. 5.3.1 Global Veterinary Lyme Disease Vaccine Sales Value by Application (2021 VS 2025 VS 2032)
  11. 5.3.2 Global Veterinary Lyme Disease Vaccine Sales Value by Application (2021-2032)
  12. 5.3.3 Global Veterinary Lyme Disease Vaccine Sales Value Share by Application (2021-2032)
6 Veterinary Lyme Disease Vaccine Regional Sales and Value Analysis
  1. 6.1 Global Veterinary Lyme Disease Vaccine Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Veterinary Lyme Disease Vaccine Sales by Region (2021-2032)
  3. 6.2.1 Global Veterinary Lyme Disease Vaccine Sales by Region: 2021-2026
  4. 6.2.2 Global Veterinary Lyme Disease Vaccine Sales by Region (2027-2032)
  5. 6.3 Global Veterinary Lyme Disease Vaccine Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Veterinary Lyme Disease Vaccine Sales Value by Region (2021-2032)
  7. 6.4.1 Global Veterinary Lyme Disease Vaccine Sales Value by Region: 2021-2026
  8. 6.4.2 Global Veterinary Lyme Disease Vaccine Sales Value by Region (2027-2032)
  9. 6.5 Global Veterinary Lyme Disease Vaccine Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  12. 6.6.2 North America Veterinary Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  15. 6.7.2 Europe Veterinary Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Veterinary Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  21. 6.9.2 South America Veterinary Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Veterinary Lyme Disease Vaccine Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Veterinary Lyme Disease Vaccine Sales Value Share by Country, 2025 VS 2032
7 Veterinary Lyme Disease Vaccine Country-level Sales and Value Analysis
  1. 7.1 Global Veterinary Lyme Disease Vaccine Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Veterinary Lyme Disease Vaccine Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Veterinary Lyme Disease Vaccine Sales by Country (2021-2032)
  4. 7.3.1 Global Veterinary Lyme Disease Vaccine Sales by Country (2021-2026)
  5. 7.3.2 Global Veterinary Lyme Disease Vaccine Sales by Country (2027-2032)
  6. 7.4 Global Veterinary Lyme Disease Vaccine Sales Value by Country (2021-2032)
  7. 7.4.1 Global Veterinary Lyme Disease Vaccine Sales Value by Country (2021-2026)
  8. 7.4.2 Global Veterinary Lyme Disease Vaccine Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Veterinary Lyme Disease Vaccine Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Veterinary Lyme Disease Vaccine Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Veterinary Lyme Disease Vaccine Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Bioveta
  2. 8.1.1 Bioveta Company Information
  3. 8.1.2 Bioveta Business Overview
  4. 8.1.3 Bioveta Veterinary Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Bioveta Veterinary Lyme Disease Vaccine Product Portfolio
  6. 8.1.5 Bioveta Recent Developments
  7. 8.2 Zoetis
  8. 8.2.1 Zoetis Company Information
  9. 8.2.2 Zoetis Business Overview
  10. 8.2.3 Zoetis Veterinary Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Zoetis Veterinary Lyme Disease Vaccine Product Portfolio
  12. 8.2.5 Zoetis Recent Developments
  13. 8.3 Boehringer Ingelheim
  14. 8.3.1 Boehringer Ingelheim Company Information
  15. 8.3.2 Boehringer Ingelheim Business Overview
  16. 8.3.3 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Boehringer Ingelheim Veterinary Lyme Disease Vaccine Product Portfolio
  18. 8.3.5 Boehringer Ingelheim Recent Developments
  19. 8.4 Elanco
  20. 8.4.1 Elanco Company Information
  21. 8.4.2 Elanco Business Overview
  22. 8.4.3 Elanco Veterinary Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Elanco Veterinary Lyme Disease Vaccine Product Portfolio
  24. 8.4.5 Elanco Recent Developments
  25. 8.5 Merck
  26. 8.5.1 Merck Company Information
  27. 8.5.2 Merck Business Overview
  28. 8.5.3 Merck Veterinary Lyme Disease Vaccine Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Merck Veterinary Lyme Disease Vaccine Product Portfolio
  30. 8.5.5 Merck Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Veterinary Lyme Disease Vaccine Value Chain Analysis
  2. 9.1.1 Veterinary Lyme Disease Vaccine Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Veterinary Lyme Disease Vaccine Sales Mode & Process
  6. 9.2 Veterinary Lyme Disease Vaccine Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Veterinary Lyme Disease Vaccine Distributors
  9. 9.2.3 Veterinary Lyme Disease Vaccine Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst